Prostate cancer clinical presentation, incidence, mortality and survival in Guadeloupe over the period 2008-2013 from a population-based cancer registry, Cancer Causes Control, vol.28, pp.1265-73, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01688592
Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans ,
, PLoS Genet, vol.7, p.1001387, 2011.
Associations of plasma concentrations of dichlorodiphenyldichloroethylene and polychlorinated biphenyls with prostate cancer: a case-control study in Guadeloupe (French West Indies), Environ Health Perspect, vol.123, pp.317-340, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01118553
Genetic susceptibility loci, pesticide exposure and prostate cancer risk, PLoS One, vol.8, p.58195, 2013. ,
Evidence for molecular differences in prostate cancer between African American and Caucasian men, Clin Cancer Res, vol.20, pp.4925-4959, 2014. ,
Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of a non-aggressive disease ,
URL : https://hal.archives-ouvertes.fr/hal-01863274
, Ann Oncol, vol.29, pp.1814-1835, 2018.
Whole-genome and transcriptome sequencing of prostate cancer identify new genetic alterations driving disease progression ,
, Eur Urol, vol.73, pp.322-361, 2018.
Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2, Nature, vol.488, pp.652-657, 2012. ,
TET2 binds the androgen receptor and loss is associated with prostate cancer, Oncogene, vol.36, pp.2172-83, 2017. ,
LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer, Biosci Biotechnol Biochem, vol.81, pp.2301-2307, 2017. ,
Inactivation of CDK12 delineates a distinct immunogenic class of advanced prostate cancer, Cell, vol.173, pp.1770-82, 2018. ,